Lifeward (LFWD) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.46% |
| Dec 31, 2025 | -32.43% |
| Sep 30, 2025 | -34.05% |
| Jun 30, 2025 | -32.17% |
| Mar 31, 2025 | -31.59% |
| Dec 31, 2024 | -31.48% |
| Sep 30, 2024 | -22.60% |
| Jun 30, 2024 | -10.75% |
| Mar 31, 2024 | -9.53% |
| Dec 31, 2023 | 31.07% |
| Sep 30, 2023 | 38.18% |
| Jun 30, 2023 | 42.58% |
| Mar 31, 2023 | 39.85% |
| Dec 31, 2022 | 44.96% |
| Sep 30, 2022 | 41.64% |
| Jun 30, 2022 | 38.96% |
| Mar 31, 2022 | 74.16% |
| Dec 31, 2021 | 85.01% |
| Sep 30, 2021 | 102.58% |
| Jun 30, 2021 | 61.49% |
| Mar 31, 2021 | 61.44% |
| Dec 31, 2020 | 7.07% |
| Sep 30, 2020 | 6.88% |
| Jun 30, 2020 | -2.26% |
| Mar 31, 2020 | -0.08% |
| Dec 31, 2019 | -8.45% |
| Sep 30, 2019 | 10.94% |
| Jun 30, 2019 | 9.07% |
| Mar 31, 2019 | -18.18% |
| Dec 31, 2018 | -16.36% |
| Sep 30, 2018 | -28.85% |
| Jun 30, 2018 | -24.22% |
| Dec 31, 2017 | -21.72% |
| Sep 30, 2017 | -26.08% |
| Dec 31, 2016 | 42.15% |